Formycon Ag · XETR:FYB
Formycon — Fact Sheet (October 2025)
1 slide from Formycon's fact sheet, October 2025
Slide 1: Formycon Fact Sheet: Development Pipeline, Partnering and Market Data
Development se III g I pipeline ha ru e e ea as as eD lP Ar Ph Ph ica nc al e l l v lin ca ca as re ro ing fe ec se ini ini p Ap Re Fil Pr Di Cl Cl * and further territories FYB201 / Ranibizumab Lucentis® Ophthalmology * FYB202 / Ustekinumab Stelara® Immunology FYB203 / Aflibercept Eylea® Ophthalmol